Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

15.41
Delayed Data
As of Jan 21
 -1.59 / -9.35%
Today’s Change
11.60
Today|||52-Week Range
38.94
-5.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues2.8M25.0M131.0M179.8M
 
 
 
 
 
Cost of Goods Sold----1.4M2.5M
 
 
 
Depreciation And Amortization1.7M3.8M4.6M4.6M
 
 
 
 
 
 
Operating ExpensesGross Income----125.0M172.7M
 
 
 
General Expenses230.2M378.7M455.4M458.2M
 
 
 
 
 
Research And Development128.2M153.9M190.2M207.3M
 
 
 
 
 
Total Operating Expenses231.9M382.5M461.4M465.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-229.2M-357.5M-330.4M-285.5M
 
 
 
 
 
Extraordinary Charge0.00-45.0M-5.2M0.00
 
 
 
Interest Expense On Debt0.0014.2M29.3M30.5M
 
 
 
 
Other Expenses2.7M3.9M4.5M6.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-226.4M-412.8M-360.4M-309.2M
 
 
 
 
 
Net Income-226.4M-412.8M-360.4M-309.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.7M24.7M25.1M28.5M
 
 
 
 
 
Shares To Calculate EPS Diluted23.7M24.7M25.1M28.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.56-$16.74-$14.38-$10.86
 
 
 
 
 
EPS Diluted-$9.56-$16.74-$14.38-$10.86